Oncology Clinical Trials Market Size Worth $16.63 Billion By 2028 | CAGR: 5.6%:Polaris Market Research

News provided by

Jul 14, 2021, 09:00 ET

NEW YORK, July 14, 2021 /PRNewswire/ -- The global oncology clinical trials market size is expected to reach USD 16.63 billion by 2028 according to a new study conducted by Polaris Market Research. the market is anticipated to register a CAGR of 5.6% 2021 – 2028. Increasing demand for personalized medication from patients detected with different forms of cancer is turned out as a key driver for the market. In addition to this, rapid innovation and evolutions in clinical trials coupled with an increasing pipeline of drug candidates are further supporting the growth of the market. The rise in investments from leading players to boost intensive research activities for the development of advanced treatment methods is projected to augment the oncology clinical trials market.

Request for a sample report: https://www.polarismarketresearch.com/industry-analysis/oncology-clinical-trials-market/request-for-sample

Key Highlights of Oncology Clinical Trials Market

Based on phase, the phase II segment accounted for the largest revenue share in the oncology clinical trials market, owing to a high number of studies that are currently under the phase II stage and its increased success rate.
In terms of study design, the segment of the interventional design held the majority of share in the market for oncology clinical trials and is expected to maintain the same trend over the forecast period. The segment's growth is attributed to its increased use as an ideal method in clinical trials.
By cancer type, the leukemia segment dominated the global market and is estimated to garner the fastest growth over the forecast period, on account of the rise in the incidence of leukemia globally, and it is also found as the most common type of cancer among children.
FDA has recently issued draft guidance regarding the inclusion of patients having incurable cancers in oncology clinical trials irrespective of their prior therapies. The administrative body believes patients struggling with such incurable cancers, if provided proper information to make a well-informed decision, must participate in oncology clinical trials.

Regional Developments

North America has dominated the oncology clinical trials market with the contribution of the highest revenue shares and is expected to witness a considerable rise in the revenue growth during the forecast period. The regional market growth can be attributed to the increasing count of cancer patients, the rise in the adoption of new technologies in clinical research, and favorable policies of governments in this region. The European market emerges as the second-fastest-growing market with increasing revenue shares of this market. On the other side, the market in the Asia Pacific region is predicted to grow as the fastest developing market owing to the increasing patient pool and improving healthcare infrastructure in the region.

Request for Discount Pricing At: https://www.polarismarketresearch.com/industry-analysis/oncology-clinical-trials-market/request-for-discount-pricing

Market Participants

The oncology clinical trials market is fragmented and highly competitive with the presence of leading international companies and new market entrants. The increasing adoption rate of advanced technology to improve overall healthcare is creating tight competition among market participants. Key players present in the global oncology clinical trials include PAREXEL International Corporation, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, ICON Plc, Wuxi AppTec, Eli Lilly and Company, Novo Nordisk A/S, Pfizer, and Clinipace.

Target Audience

Supply Side: Clinical Research Organization
Demand Side: Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs)
Regulatory Side: World Health Organization

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/oncology-clinical-trials-market/speak-to-analyst

Polaris Market Research has segmented the oncology clinical trials market report on the basis of phase, study design, cancer type, and region:

Oncology Clinical Trials, Phase Outlook (Revenue – USD Million, 2016 – 2028)

Phase I
Phase II
Phase III
Phase IV

Oncology Clinical Trials, Study Design Outlook (Revenue – USD Million, 2016 – 2028)

Interventional
Observational
Expanded Access

Oncology Clinical Trials, Cancer Type Outlook (Revenue – USD Million, 2016 – 2028)

Lung cancer
Breast cancer
Thyroid cancer
Leukemia
Liver cancer
Skin cancer
Lymphoma
Pancreatic cancer
Prostate cancer
Colon & rectal cancer
Urinary system cancer
Other cancer

Oncology Clinical Trials, by Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

U.S.
Canada

Europe

France
Germany
UK
Italy
Spain
Netherlands
Austria

Asia Pacific

China
India
Japan
Malaysia
South Korea
Indonesia

Central & South America

Mexico
Brazil
Argentina

Middle East & Africa

UAE
Saudi Arabia
Israel
South Africa

Find more research reports on Healthcare by PMR

Medical Devices Reimbursement Market Share, Size, Trends, Industry Analysis Report, By Payer (Public, Private); By Healthcare Setting (Hospitals, Outpatient Facilities, Others); By Regions; Segment Forecast, 2021 – 2028

Healthcare Patent Filing Outsourcing Market Share, Size, Trends, Industry Analysis Report, By Domain (MedTech, Pharmaceutical); By Service (Pre-filing, Filing & Prosecution, Post Grant); By Origin (Resident, Non-resident); By Regions; Segment Forecast, 2021 – 2028

Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2025

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-917-985-9017
Email: [email protected]
Web: https://www.polarismarketresearch.com/
Follow US: LinkedIn | twitter